TrialGut2005

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.

E Furrie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.